Skip to main content

Table 3 Health and economic outcomes and neuropsychiatric symptom measures for early AD

From: Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease

Domain

Potential Measure

Health and economic outcomes

Resource Utilization in Dementia (RUD) Questionnaire

 • Structured interview with study partner to obtain information about patient and caregiver, including [55]

  o Healthcare resource utilization

  o Work status

  o Living accommodations

  o Level of formal and informal care attributable to AD, including caregiving time spent assisting patient’s instrumental ADLs or basic ADLs

 • Emerging evidence leveraging the RUD indicates that early AD, including MCI, poses a financial burden to the patient, caregiver, and society [56]

Neuropsychiatric symptoms

Neuropsychiatric Inventory [57]

 • 12-item informant-based interview about delusions, hallucinations, anxiety, depression, agitation/aggression, euphoria, disinhibition, irritability/lability, apathy, aberrant motor activity, night-time behavioral disturbances, and appetite/eating abnormalities

 • Widely accepted measure of neuropsychiatric symptoms in dementia

Mild Cognitive Behavioral Impairment Checklist (MBI-C) [58]

 • Specifically developed as an MBI case ascertainment instrument, which also allows for the monitoring of MBI symptoms over time

 • 34-item instrument for completion by patient, close informant, or clinician

 • Assesses 5 domains of (1) decreased motivation; (2) emotional dysregulation; (3) impulse dyscontrol; (4) social inappropriateness; and (5) abnormal perception or thought content